341 related articles for article (PubMed ID: 31740938)
1. Modified Vaccinia Ankara-Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T Cells in Human Nasopharynx-Associated Lymphoid Tissue.
Puksuriwong S; Ahmed MS; Sharma R; Krishnan M; Leong S; Lambe T; McNamara PS; Gilbert SC; Zhang Q
J Infect Dis; 2020 Aug; 222(5):807-819. PubMed ID: 31740938
[TBL] [Abstract][Full Text] [Related]
2. Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.
Mullin J; Ahmed MS; Sharma R; Upile N; Beer H; Achar P; Puksuriwong S; Ferrara F; Temperton N; McNamara P; Lambe T; Gilbert SC; Zhang Q
Vaccine; 2016 Mar; 34(14):1688-95. PubMed ID: 26902548
[TBL] [Abstract][Full Text] [Related]
3. A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.
Antrobus RD; Lillie PJ; Berthoud TK; Spencer AJ; McLaren JE; Ladell K; Lambe T; Milicic A; Price DA; Hill AV; Gilbert SC
PLoS One; 2012; 7(10):e48322. PubMed ID: 23118984
[TBL] [Abstract][Full Text] [Related]
4. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.
Berthoud TK; Hamill M; Lillie PJ; Hwenda L; Collins KA; Ewer KJ; Milicic A; Poyntz HC; Lambe T; Fletcher HA; Hill AV; Gilbert SC
Clin Infect Dis; 2011 Jan; 52(1):1-7. PubMed ID: 21148512
[TBL] [Abstract][Full Text] [Related]
5. Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge.
McMahon M; Asthagiri Arunkumar G; Liu WC; Stadlbauer D; Albrecht RA; Pavot V; Aramouni M; Lambe T; Gilbert SC; Krammer F
Front Immunol; 2019; 10():2005. PubMed ID: 31497029
[TBL] [Abstract][Full Text] [Related]
6. OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza.
Del Campo J; Bouley J; Chevandier M; Rousset C; Haller M; Indalecio A; Guyon-Gellin D; Le Vert A; Hill F; Djebali S; Leverrier Y; Marvel J; Combadière B; Nicolas F
Front Immunol; 2021; 12():678483. PubMed ID: 34177921
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.
Di Mario G; Sciaraffia E; Facchini M; Gubinelli F; Soprana E; Panigada M; Bernasconi V; Garulli B; Siccardi A; Donatelli I; Castrucci MR
Pathog Glob Health; 2017 Mar; 111(2):76-82. PubMed ID: 28079473
[TBL] [Abstract][Full Text] [Related]
8. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
9. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.
Lee LY; Ha do LA; Simmons C; de Jong MD; Chau NV; Schumacher R; Peng YC; McMichael AJ; Farrar JJ; Smith GL; Townsend AR; Askonas BA; Rowland-Jones S; Dong T
J Clin Invest; 2008 Oct; 118(10):3478-90. PubMed ID: 18802496
[TBL] [Abstract][Full Text] [Related]
10. Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.
Magini D; Giovani C; Mangiavacchi S; Maccari S; Cecchi R; Ulmer JB; De Gregorio E; Geall AJ; Brazzoli M; Bertholet S
PLoS One; 2016; 11(8):e0161193. PubMed ID: 27525409
[TBL] [Abstract][Full Text] [Related]
11. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.
Aslan N; Watkin LB; Gil A; Mishra R; Clark FG; Welsh RM; Ghersi D; Luzuriaga K; Selin LK
mBio; 2017 Dec; 8(6):. PubMed ID: 29208744
[TBL] [Abstract][Full Text] [Related]
12. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
[TBL] [Abstract][Full Text] [Related]
13. Immunity to Respiratory Infection Is Reinforced Through Early Proliferation of Lymphoid T
Suarez-Ramirez JE; Chandiran K; Brocke S; Cauley LS
Front Immunol; 2019; 10():1370. PubMed ID: 31258537
[TBL] [Abstract][Full Text] [Related]
14. Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.
Machkovech HM; Bedford T; Suchard MA; Bloom JD
J Virol; 2015 Nov; 89(22):11275-83. PubMed ID: 26311880
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
Veit S; Jany S; Fux R; Sutter G; Volz A
Viruses; 2018 Dec; 10(12):. PubMed ID: 30558354
[TBL] [Abstract][Full Text] [Related]
16. Assessment of CD8
Evans TG; Castellino F; Kowalik Dobczyk M; Tucker G; Walley AM; Van Leuven K; Klein J; Rutkowski K; Ellis C; Eagling-Vose E; Treanor J; van Baalen C; Filkov E; Laurent C; Thacker J; Asher J; Donabedian A
Lancet Microbe; 2024 May; ():. PubMed ID: 38729196
[TBL] [Abstract][Full Text] [Related]
17. Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
Powell TJ; Peng Y; Berthoud TK; Blais ME; Lillie PJ; Hill AV; Rowland-Jones SL; McMichael AJ; Gilbert SC; Dong T
PLoS One; 2013; 8(5):e62778. PubMed ID: 23658773
[TBL] [Abstract][Full Text] [Related]
18. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
[TBL] [Abstract][Full Text] [Related]
19. Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8
Knight FC; Gilchuk P; Kumar A; Becker KW; Sevimli S; Jacobson ME; Suryadevara N; Wang-Bishop L; Boyd KL; Crowe JE; Joyce S; Wilson JT
ACS Nano; 2019 Oct; 13(10):10939-10960. PubMed ID: 31553872
[TBL] [Abstract][Full Text] [Related]
20. Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses.
Antrobus RD; Berthoud TK; Mullarkey CE; Hoschler K; Coughlan L; Zambon M; Hill AV; Gilbert SC
Mol Ther; 2014 Jan; 22(1):233-8. PubMed ID: 23831594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
